Table 6.

Results of Quality of Life Assessment (EORTC QLQ-30C and BR23 Questionnaires) in Groups of Patients with Different Levels of Illness Acceptance and Analysis of Variance

Quality of Life		Level of Acceptance of the Illness (AIS) (Me±SD)			ANOVA p
		Lack of Acceptance 8–29 Points	Medium 30–34 Points	High 35–40 Points
		N =24	N =51	N=75
Scale of symptoms QLQ-C30	Fatigue	51.0±21.5	42.7±21.4	34.3±21.0	<0.001
	Nausea and vomiting	35.9±36.4	17.1±24.6	6.4±17.8	<0.001
	Pain	44.8±24.5	31.2±24.9	21.1±23.0	<0.001
	Dyspnoea	34.4±35.4	10.8±23.4	10.6±20.0	<0.001
	Insomnia	46.9±31.5	42.6±33.0	37.0±34.3	0.278
	Appetite loss	40.6±31.4	24.2±28.5	12.2±22.5	<0.001
	Constipation	31.2±31.6	24.6±19.5	14.9±24.3	0.001
	Diarrhoea	35.4±33.8	6.3±15.4	6.3±17.5	<0.001
	Financial difficulties	45.8±32.5	33.3±28.0	22.7±28.4	<0.001
Scale of functioning QLQ-BR23	Body image	30.3±25.9	46.3±28.4	51.0±25.2	<0.001
	Sexual functioning	29.2±29.9	43.5±29.6	47.4±29.1	0.001
	Sexual enjoyment	14.7±27.4	40.2±31.7	46.1±37.5	<0.001
	Future perspective	70.8±29.0	80.9±26.6	66.7±32.0	0.010
Scale of symptoms QLQ-BR23	Treatment side effects	41.8±20.9	32.9±19.7	22.9±17.1	<0.001
	Breast problems	42.5±30.2	33.7±24.2	19.0±20.8	<0.001
	Arm problems	45.1±23.5	37.4±26.1	31.0±22.5	0.011
	Hair loss	54.7±30.3	61.7±35.9	46.8±35.9	0.141
EORTC QLQ-30C	Overall quality of life	37.8±24.4	64.7±16.3	64.7±16.3	<0.001
	Physical functioning	19.9±13.7	40.4±24.4	40.4±24.4	<0.001
	Functioning in daily activities	15.0±17.1	39.1±28.3	39.1±28.3	<0.001
	Emotional functioning	30.1±19.9	53.1±25.3	53.1±25.3	<0.001
	Cognitive functioning	18.6±20.3	43.2±32.5	43.2±32.5	<0.001
	Social functioning	22.3±20.2	47.4±29.1	47.4±29.1	<0.001